Google
Trusted Resources: News & Events
Latest announcements and gatherings
An Introduction to the Institute for Clinical Economic Review (ICER) and Their Implications for New Sickle Cell Disease Treatments: A Primer on the Issues
January 16, 2020
2:00 – 3:00 PM ET
We welcome interested stakeholders, patients, advocates, caregivers and families to join a webinar providing information about the metric used to assess the value of health care treatments called the quality-adjusted life year or “QALY” as well as the primary organization conducting QALY-based value assessments called the Institute for Clinical Economic Review (ICER). Because ICER will assess the value of new sickle cell disease treatments in March, 2020, it is important for all stakeholders to understand QALYs, ICER and how those value assessments may be used by public and private payers in their decisions related to drug coverage and formularies.
We are excited to have Sara van Geertruyden with the Partnership to Improve Patient Care (PIPC) join us to present information about QALYs and ICER. Other stakeholders will provide specific information about their experience with ICER so far as they determine the scope of their upcoming report, the sickle cell disease treatments under review, and an overview of treatments in the development pipeline.
This event has ended.
+myBinderRelated Content
-
Thalassaemia and Sickle Cell Society of AustraliaThalassaemia and Sickle Cell Australia (...
-
Improving Vaso-Occlusive Crisis ManagementMany have spoken out about the need for ...
-
What’s in your genes?https://www.youtube.com/watch?v=ggeqOj07...
-
National Sickle Cell Advocacy Day 2020 — Sickle Cell Disease Association of America – CANCELEDPlease join the Sickle Cell Disease Asso...
-
SCD Clinical Trials Network Workshop – New York, NYJoin us for an afternoon of fun acti...
-
Sickle Cell Foundation Inc.The Sickle Cell Foundation of the Big Be...
-
GBT launches ACCEL grants program to improve access to care for people with Sickle cell diseaseGlobal Blood Therapeutics, Inc. (GBT) to...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.